Medicago inc. – Trademark Portfolio
Entity Type: 03
Medicago inc. holds 40 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 33 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 20 trademarks are registered. Notable registered marks include M, ADCOVAX, COVIMIC, COVIXTA, and MYRIFLU.
1020, route de l'Église, bureau 600
Québec QC G1V 3V9
Showing of trademarks Trademarks
Trademark Classifications
Medicago inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Medicago inc. have?
Medicago inc. has 40 U.S. trademarks filed with the USPTO. Of these, 20 registered, 18 abandoned, 2 cancelled.
What trademark classes does Medicago inc. file in?
Medicago inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Medicago inc.'s most well-known trademarks?
Medicago inc.'s registered trademark portfolio includes well-known marks such as M, ADCOVAX, COVIMIC, COVIXTA, and MYRIFLU. These are among 20 currently registered trademarks in the portfolio.
What is Medicago inc.'s trademark registration success rate?
Medicago inc. has a 50% trademark registration rate, with 20 out of 40 resolved applications resulting in successful registration. Currently, 0 applications are pending review.